Cell therapy in Huntington disease

Neurosurgical Focus

Volumn 24, Issue 3-4, 2008, Pages

  Clelland, Claire D ^a,b   Barker, Roger A ^a   Watts, Colin ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Cell therapy; Huntington disease; Neurogenesis; Neurotrophic factor; Transplantation

Indexed keywords

ANIMAL; BIOLOGICAL THERAPY; HUMAN; HUNTINGTON CHOREA; METHODOLOGY; REVIEW;

ANIMALS; HUMANS; HUNTINGTON DISEASE; TISSUE THERAPY;

EID: 42149128432     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/FOC/2008/24/3-4/E7     Document Type: Article

References (165)

1. Akerud P, Canals JM, Snyder EY, Arenas E: Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J Neurosci 21:8108-8118, 2001
2. Altman J: Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol 137:433-457, 1969
3. Altman J, Das GD: Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124: 319-335, 1965
4. Anderson KD, Panayotatos N, Corcoran TL, Lindsay RM, Wiegand SJ: Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc Natl Acad Sci U S A 93:7346-7351, 1996
5. Andrews TC, Weeks RA, Turjanski N, Gunn RN, Watkins LH, Sahakian B, et al: Huntington's disease progression. PET and clinical observations. Brain 122:2353-2363, 1999
6. Anonymous: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72:971-983, 1993
7. Araujo DM, Hilt DC: Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease. Neuroscience 81:1099-1110, 1997
8. Armstrong RJ, Barker RA: Neurodegeneration: a failure of neuroregeneration? Lancet 358:1174-1176, 2001
9. Armstrong RJ, Watts C, Svendsen CN, Dunnett SB, Rosser AE: Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant 9:55-64, 2000
10. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O: Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8:963-970, 2002
11. Arvidsson A, Kokaia Z, Lindvall O: N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur J Neurosci 14:10-18, 2001
12. Bachoud-Lévi A, Bourdet C, Brugières P, Nguyen JP, Grandmougin T, Haddad B, et al: Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol 161:194-202, 2000
13. Bachoud-Lévi AC, Gaura V, Brugières P, Lefaucheur JP, Boissé MF, Maison P, et al: Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 5:303-309, 2006
14. Bachoud-Lévi AC, Hantraye P, Peschanski M: Fetal neural grafts for Huntington's disease: a prospective view. Mov Disord 17: 439-444, 2002
15. Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, et al: Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356:1975-1979, 2000
16. Baquet ZC, Gorski JA, Jones KR: Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24:4250-4258, 2004
17. Barker RA, Widner H: Immune problems in central nervous system cell therapy. NeuroRx 1:472-41, 2004
18. Beal MF, Brouillet E. Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, et al: Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181-4192, 1993
19. Bemelmans AP, Horellou P, Pradier L, Brunet I, Colin P, Mallet J: Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 10:2987-2997, 1999
20. Benoit BO, Savarese T, Joly M, Engstrom CM, Pang L, Reilly J, et al: Neurotrophin channeling of neural progenitor cell differentiation. J Neurobiol 46:265-280, 2001
21. Bernreuther C, Dihné M, Johann V, Schiefer J, Cui Y, Hargus G, et al: Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum. J Neurosci 26:11532-11539, 2006
22. Bloch J, Bachoud-Lévi AC, Déglon N, Lefaucheur, JP, Winkel L, Palfi S, et al: Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum Gene Ther 15:968-975, 2004
23. Brundin P, Fricker RA, Nakao N: Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease. Neuroscience 71:895-897, 1996
24. Caldwell MA, He X, Wilkie N, Pollack S, Marshall G, Waffold KA, et al Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol 19:475-479, 2001
25. Campbell K, Kalén P, Wictorin K, Lundberg C. Mandel RJ, Björklund A: Characterization of GABA release from intrastriatal striatal transplants: dependence on host-derived afferents. Neuroscience 53:403-415, 1993
26. Canals JM, Checa N, Marco S, Akerud P, Michels A, Pérez-Navarro E, et al: Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area. J Neurosci 21:117-124, 2001
27. Carlén M, Cassidy RM, Brismar H, Smith GA, Enquist LW, Frisén J: Functional integration of adult-born neurons. Curr Biol 12:606-608, 2002
28. Carleton A, Petreanu LT, Lansford R, Alvarez-Buylla A, Lledo PM: Becoming a new neuron in the adult olfactory bulb. Nature Neurosci 6:507-518, 2003
29. Caruncho HJ, Rodríguez-Pallares J, Guerra MJ, Labandeira-García JL: Mature intrastriatal striatal grafts revert the changes in the expression of pallidal and thalamic alpha 1, alpha 2 and beta 2/3 GABAA receptor subunit induced by ibotenic acid lesions in the rat striatum. Brain Res Mol Brain Res 57:301-309, 1998
30. Chen J, Magavi SS, Macklis JD: Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice. Proc Ntld Acad Sci U S A 101:16357-16362, 2004
31. Chen Y, Swanson RA: Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137-149, 2003
32. Cho SR, Benraiss A, Chmielnicki E, Samdani A, Economides A, Goldman SA: Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease. J Clin Invest 117:2889-2902, 2007
33. Ciccolini F, Svendsen CN: Neurotrophin responsiveness is differentially regulated in neurons and precursors isolated from the developing striatum. J Mol Neurosci 17:25-33, 2001
34. Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, Wikkelso C, et al: Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science 315:1243-1249, 2007
35. Curtis MA, Penney EB, Pearson AG, van Roon-Mom WM, Butterworth NJ, et al: Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A 100:9023-9027, 2003
36. Curtis MA, Penney EB, Pearson J, Dragunow M, Connor B, Faull RL: The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience 132:777-788, 2005
37. Curtis MA, Waldvogel HJ, Synek B, Faull RL: A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain. J Chem Neuroanat 30:55-66, 2005
38. de Almeida LP, Zala D, Aebischer P, Déglon N: Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease. Neurobiol Dis 8:433-446, 2001
39. Dihné M, Bernreuther C, Hagel C, Wesche KO, Schachner M: Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells 24:1458-1466, 2006
40. Dinsmore J, Ratliff J, Deacon T, Pakzaban P, Jacoby D, Galpern W, et al: Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. Cell Transplant 5:131-143, 1996
41. Döbrössy MD, Dunnett SB: Environmental enrichment affects striatal graft morphology and functional recovery. Eur J Neurosci 19:159-168, 2004
42. Döbrössy MD, Dunnett SB: The influence of environment and experience on neural grafts. Nat Rev Neurosci 2:871-879, 2001
43. Döbrössy MD, Dunnett SB: Motor training effects on recovery of function after striatal lesions and striatal grafts. Exp Neurol 184: 274-284, 2003
44. Döbrössy MD, Dunnett SB: Training specificity, graft development and graft mediated functional recovery in a rodent model of Huntington's disease. Neuroscience 132:543-552, 2005
45. Dunnett SB, Carter RJ, Watts C, Torres EM, Mahal A, Mangiarini L, et al: Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp Neurol 154:31-40, 1998
46. Dziewczapolski G, Lie DC, Ray J, Gage FH, Shults CW: Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats. Exp Neurol 183:653-664, 2003
47. Emerich DF, Bruhn S, Chu Y, Kordower JH: Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease. Cell Transplant 7:213-225, 1998
48. Emerich DF, Lindner MD, Winn SR, Chen EY, Frydel BR, Kordower JH: Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J Neurosci 16:5168-5181, 1996
49. Emerich DF, Winn SR: Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum. Cell Transplant 13:253-259, 2004
50. Emerich DF, Winn SR, Hantraye PM, Peschanski M, Chen EY, Chu Y, et al: Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386:395-399, 1997
51. Ende N, Chen R: Human umbilical cord blood cells ameliorate Huntington's disease in transgenic mice. J Med 32:231-240, 2001
52. Englund U, Bjorklund A, Wictorin K, Lindvall O, Kokaia M: Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc Natl Acad Sci U S A 99:17089-17094, 2002
53. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al: Neurogenesis in the adult human hippocampus. Nat Med 4:1313-1317, 1998
54. Ferrante RJ, Kowall NW, Cipolloni PB, Storey, E, Beal MF: Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp Neurol 119:46-71, 1993
55. Foroud T, Gray J, Ivashina J, Conneally PM: Differences in duration of Huntington's disease based on age at onset J Neurol Neurosurg Psychiatry 66:52-56, 1999
56. Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, et al: Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A 97:13877-13882, 2000
57. Fricker RA, Carpenter MK, Winkler C, Greco C, Gates MA, Björklund A: Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 19:5990-6005, 1999
58. Fricker-Gates RA, Muir JA, Dunnett SB: Transplanted hNT cells ("LBS neurons") in a rat model of huntington's disease: good survival, incomplete differentiation, and limited functional recovery. Cell Transplant 13:123-136, 2004
59. Furtado S, Sossi V, Hauser RA, Samii A, Schulzer M, Murphy CB, et al: Positron emission tomography after fetal transplantation in Huntington's disease. Ann Neurol 58:331-337, 2005
60. Fusco FR, Zuccato C, Tartari M, Martorana A, De March Z, Giampà C, et al: Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. Eur J Neurosci 18:1093-1102, 2003.
61. Gage FH, Ray J. Fisher LJ: Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 18:159-192, 1995
62. Gaura. V, Bachoud-Lévi AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S. et al: Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 127:65-72, 2003
63. Gil JM, Leist M, Popovic N, Brundin P, Petersén A: Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice. BMC Neurosci 5:17, 2004
64. Gil JM, Mohapel P, Araújo IM, Popovic N, Li JY, Brundin P, et al: Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiol Dis 20:744-751, 2005
65. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ: Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 2:260-265, 1999
66. Gratacòs E, Pérez-Navarrro E, Tolosa E, Arenas E, Alberch J: Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J Neurochem 78: 1287-1296, 2001
67. Grote HE, Bull ND, Howard ML, van Dellen A, Blakemore C, Bartlett PF, et al: Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur J Neurosci 22:2081-2088, 2005
68. Gu X, André VM, Cepeda C, Li SH, Li XJ, Levine MS, et al: Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease. Mol Neurodegener 2:8, 2007
69. Gu X, Li C, Wei W, Lo V, Gong S, Li SH, et al: Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46:433-444, 2005
70. Hantraye P, Riche D, Maziere M, Isacson O: Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. Proc Natl Acad Sci U S A 89:4187-4191, 1992
71. Harper PS: Huntington's Disease. Philadelphia, WB Saunders, 1996
72. Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S, et al: Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 58:687-695, 2002
73. Höglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, et al: Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 7:726-735, 2004
74. Hurelbrink CB, Armstrong RJ, Barker RA, Dunnett SB, Rosser AE: Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease. Cell Transplant 9:743-749, 2000
75. Hurelbrink CB, Armstrong RJ, Dunnett SB, Rosser AE, Barker RA: Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS. Eur J Neurosci 15:1255-1266, 2002
76. Hurelbrink CB, Tyers P, Armstrong RJ, Dunnett SB, Barker RA, Rosser AE: Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington:s disease. Cell Transplant 12:687-695, 2003
77. Isacson O, Deacon TW, Pakzaban P, Galpern WR, Dinsmore J, Burns LH: Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibers. Nat Med 1:1189-1194, 1995
78. Jessberger S. Kempermann G: Adult-born hippocampal neurons mature into activity-dependent responsiveness. Eur J Neurosci 18:2707-2712, 2003
79. Jin K, LaFevre-Bernt M, Sun Y, Chen S, Gafni J. Crippen D, et al: FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci U S A 102:18189-181949, 2005
80. Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, et al: Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A 98:4710-4715, 2001
81. Johann V, Schiefer J, Sass C, Mey J, Brook G, Krüttgen A, et al: Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Exp Brain Res 177:458-470, 2007
82. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J: Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25-34, 1999
83. Keene CD, Sonnen JA Swanson PD, Kopyov O, Leverenz JB, Bird TD, et al: Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology 68:2093-2098, 2007
84. Kendall AL, Rayment FD, Torres EM, Baker HF, Ridley RM, Dunnett SB: Functional integration of striatal allografts in a primate model of Huntington's disease. Nat Med 4:727-729, 1998
85. Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS: Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 149:97-108, 1998
86. Kordower JH, FreemnTB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, et al: Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 13: 383-393, 1998
87. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg; PR, et al: Neuropadiological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124, 1995
88. Kremer B, Clark CM, Almqvist EW, Raymond LA, Graf P, Jacova C, et al: Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial. Neurology 53:1000-1011, 1999
89. Lazic SE, Grote H, Armstrong RJ, Blakemore C, Hannam AJ, van Dellen A, et al: Decreased hippocampal cell proliferation in R6/1 Huntington's mice. Neuroreport 15:811-813, 2004
90. Lazic SE, Grote HE, Blakemore C, Hannan AJ, van Dellen A, Phillips W, et al: Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment. Eur J Neurosci 23:1829-1838, 2006
91. Lescaudron L, Unni D, Dunbar GL: Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes. Int J Neurosci 113:945-956, 2003
92. Levivier M, Gash DM, Przedborski S: Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum. Neuroscience 69: 43-50, 1995
93. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW: Pro-regenerative properties of cytokine-activated astrocytes. J Neurochein 89:1092-1100, 2004
94. Lie DC, Colamarino SA, Song HJ, Désiré L, Mira K Consiglio A, et al: Wnt signalling regulates adult hippocampal neurogenesis. Natnre 437:1370-1375, 2005
95. Lie DC, Dziewczapolski G, Willhoite AR, Kaspar BK, Shults CW, Gage FH: The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 22:6639-6649, 2002
96. Lie DC, Song H, Colamarino SA, Ming GL, Gage FH: Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol 44:399-421, 2004
97. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, et al: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577, 1990
98. Liu FC, Dunnett SB, Graybiel AM: Influeuce of mesostriatal afferents on the development and transmitter regulation of intrastriatal grafts derived from embryonic striatal primordia. J Neurosci 12:4281-4297, 1992
99. Liu J, Solway K, Messing RO, Sharp FR: Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci 18:7768-7778, 1998
100. Lois C, García-Verdugo JM, Alvarez-Buylla A: Chain migration of neuronal precursors. Science 271:978-981, 1996
101. López-Martín E, Caruncho HJ, Rodríguez-Pallares J, Guerra MJ, Pbandeira-Garcia _JL: Siriat~l d9paminergic afferents concentrate-in GDNF-positive patches during development and in developing intrastriatal striatal grafts. J Comp Neurol 406:199-206, 1999
102. Lu P, Jones LL, Snyder EY, Tuszynski MH: Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181:115-129, 2003
103. Madrazo I, Franco-Bourland RE, Castrejon H, Cuevas C, Ostrosky-Solis F: Fetal striatal homotransplantation for Huntington's disease: first two case reports. NeurolRes 17:312-315, 1995
104. Magavi SS, Leavitt BR, Macklis JD: Induction of neurogenesis in the neocortex of adult mice. Nature 405:951-955, 2000
105. Marco S, Canudas AM, Canals JM, Gavaldá N, Pérez-Navarro E, Alberch J: Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum. Exp Neurol 174:243-252, 2002
106. McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN, et al: Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol 475:211-219, 2004
107. McBride JL, During MJ, Wuu J, Chen EY, Leurgans SE, Kordower JH: Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Exp Neurol 181:213-223, 2003
108. McBride JL, Ramaswamy S, Gasmi M, Bartus RT, Herzog CD, Brandon EP, et al: Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A 103:9345-9350, 2006
109. Ming GL. Song H: Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28:223-250, 2005
110. Mittoux V, Joseph JM, Conde F, Palfi S, Dautry C, Poyot T, et al: Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. Hum Gene Ther 11: 1177-1187, 2000
111. Mittoux V, Ouary S, Monville C, Lisovoski F, Poyot T, Conde F, et al: Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration. J Neurosci 22: 4478-4486, 2002
112. Nakao N, Brundin P, Funa K, Lindvall O, Odin P: Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res Dev Brain Res 90:92-101, 1995
113. Nakao N, Ogura M. Nakai K, Itakura. T: Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease. Neuroscience 88:469-477, 1999
114. Ostenfeld T, Svendsen CN: Recent advances in stem cell neurobiology. Adv Tech Stand Neurosurg 28:3-89, 2003
115. Palfi S, Condé F. Riche D, Brouillet E, Dautry C, Mittoux V, et al: Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat Med 4:963-966, 1998
116. Palmer TD, Ray J, Gage FH: FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol Cell Neurosci 6:474-486, 1995
117. Palmer TD, Willhoite AR, Gage FH: Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425:479-494, 2000
118. Pang TY, Stain NC, Nithianantharajah J, Howard ML, Hannan AJ: Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 141:569-584, 2006
119. Parent JM, Valentin VV, Lowenstein DH: Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J Neurosci 22:3174-3188, 2002
120. Parent JM, Yu TW, Leibowitz RT, Geschwind DH, Sloviter RS, Lowenstein DH: Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 17: 3727-3738, 1997
121. Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, et al: Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain 126:1127-1135, 2003
122. Pérez-Navarro E, Arenas E, Reiriz J, Calvo N, Alberch J: Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage. Neuroscience 75:345-352, 1996
123. Pérez-Navarro E, Canudas AM, Akerund P, Alberch J, Arenas E: Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J Neurochem 75: 2190-2199, 2000
124. Phillips W, Morton AJ, Barker RA: Abnormalities of neurogenesis in the R612 mouse model of Huntington's disease are attributable to the in vivo microenvironment. J Neurosci 25: 11564-11576, 2005
125. Philpott LM, Kopyov OV, Lee AJ, Jacques S, Duma CM, Caine S, et al: Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations. Cell Transplant 6:203-212, 1997
126. Piccini P, Brooks DJ, Björklund A, Gunn RN, Grasby PM, Rimoldi O, et al: Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2: 1137-1140, 1999
127. Pineda JR, Rubio N, Akerud P, Urbán N, Badimon L, Arenas E, et al: Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells. Gene Ther 14:118-128, 2007
128. Régulier E, Pereira de Almeida L, Sommer B, Aebischer P, Déglon N: Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum Gene Ther 13:1981-1990, 2002
129. Reynolds BA, Weiss S: Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175:1-13, 1996
130. Rodriguez AI, Willing AE, Saporta S, Cameron DF, Sanberg PR: Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study. Neurotox Res 5:443-450, 2003
131. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, et al: Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615-1620, 2003
132. Ross BD, Hoang TQ, Blüml Dubowitz D, Kopyov OV, Jacques DB, et al: In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR Biomed 12:221-236, 1999
133. Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AYC, et al: Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry 73:678-685, 2002
134. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al: Requirement of hippocarapal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809, 2003
135. Scharfman HE, Goodman JH, Sollas AL: Granule-like neurons at the hilar/ CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J Neurosci 20:6144-6158, 2000
136. Seri B, García-Verdugo JM, Collado-Morente L, McEwen BS, Alvarez-Buylla A: Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus. J Comp Neurol 478: 359-378, 2004
137. Shihabuddin LS, Horner PJ, Ray J, Gage FH: Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyms. J Neurosci 20:8727-8735, 2000
138. Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E: Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372-376, 2001
139. Song H, Stevens CF, Gage FH: Astroglia induce neurogenesis from adult neural stem cells. Nature 417:39-44, 2002
140. Song HJ, Stevens CF, Gage FH: Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat Neurosci 5:438-445, 2002
141. Song J, Lee ST, Kang W, Park JE, Chu K, Lee SE, et al: Human embryonic stem cell derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions. Neurosci Lett 423:58-61, 2007
142. Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, et al: Unilateral transplantation of human fetal mesencephatic tissue into the caudate nucleus of patients with Parkinson's disease. N Eugl J Med 327:1541-1548, 1992
143. Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, et al: Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J Neurosci 24:2270-2276, 2004
144. Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C, et al: Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27: 11758-11768, 2007
145. Suhonen JO, Peterson DA, Ray J, Gage FH: Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature 383:624-627, 1996
146. Tattersfield AS, Croon RJ, Liu YW, Kells AP, Faull RL, Connor B: Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease. Neuroscience 127:319-332, 2004
147. Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW: Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci U S A 97:8093-8097, 2000
148. van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ: Delaying the onset of Huntington's in mice. Nature 404:721-722, 2000
149. van Dellen A, Deacon R, York D, Blakemore C, Hannan AJ: Anterior cingulate cortical transplantation in transgenic Huntington's disease mice. Brain Res Bull 56:313-318, 2001
150. van Praag H, Christie BR, Sejnowski TJ, Gage FH: Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sd U S A 96:13427-13431, 1999
151. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH: Functional neurogenesis in the adult hippocampus. Nature 415:1030-1034, 2002
152. Vazey EM, Chen K, Hughes SM, Connor B: Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Exp Neurol 199:384-396, 2006
153. Ventimiglia R, Mather PE, Jones BE, Lindsay RM: The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 7:213-222, 1995
154. Visnyei Y, Tatsukawa KJ, Erickson RL Simonian S, Oknaian N, Carmichael ST, et al: Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp Neurol 197:465-474, 2006
155. Vonsattel JP, DiFiglia M: Huntington disease. J Neuropathol Exp Neurol 57:369-384, 1998
156. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr: Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577, 1985
157. Watts C, Brasted PJ, Dunnett SB: Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Exp Neurol 163:85-97, 2000
158. Wichterle H, Garcia-Verdugo JMI Alvarez-Buylla A: Direct evidence for homotypic, glia-independent neuronal migration. Neuron 18:779-791, 1997
159. Yamamoto A, Lucas JJ, Hen R: Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101:57-66, 2000
160. Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM: Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci 27: 11925-11933, 2007
161. Yu ZX, Li SH, Evans J, Pillarisetti A, Li H, Li XJ: Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's
162. Zala D, Bensadoun JC, Pereira de Almeida L, Leavitt BR, Gutekunst CA, Aebischer P, et al: Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice. Exp Neurol 185:26-35, 2004
163. Zuccato C, Belyaev N, Conforti P, Ooi L, Tartari M, Papadimou E. et al: Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J Neurosci 27:6972-6983, 2007
164. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, et al: Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293:493-498, 2001
165. Zuccato C, Liber D, Ramos C. Tarditi A, Rigamonti D. Tartari M,: Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacol Res 52:133-139, 2005